Key points：
- British American Tobacco has appointed Matthew Wright as an independent non-executive director, effective from November 1, 2025.
- Wright will join the Remuneration Committee and the Nominations Committee.
- With extensive experience in international executive recruitment and organizational transformation, Wright has held multiple positions at Mercer Consulting.
- The Chairman of BAT's Board of Directors stated that the appointment will support the company's cultural transformation and focus on their smoke-free strategy.
In a press release dated October 15, 2025, British American Tobacco p.l.c. announced that Matthew Wright will be joining the company's board of directors as an independent non-executive director on November 1, 2025. Wright will also serve as a member of the remuneration committee and the nomination committee.
Wright has extensive international executive consulting and leadership experience, focusing their career on helping large enterprises recruit and develop senior management talent during periods of transformation and growth.
Between 1993 and 2013, he held multiple positions at Russell Reynolds Associates, including CEO, president, and board member, responsible for the firm's operations in Asia and Europe. He also served on the global executive and operating committees. Prior to this, he had worked at Korn/Ferry International, Knight Wendling, and Cripps Leadership Advisors.
Chairman of the British American Tobacco Board of Directors, Luc Jobin, stated: "We welcome Wright's addition to the board. Cultural transformation is crucial for BAT's sustainable future, and his addition will further strengthen this process. His leadership experience in multinational organizations in Asia, Europe, and the United States will bring valuable insights to the company.
Wright currently serves as a non-executive director and chair of the remuneration committee at Berry Bros. & Rudd Ltd. He is also the chairman of Cripps Leadership Advisors and holds advisory and chair positions at Movemeon.
Image source: British American Tobacco p.l.c.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
